24 de noviembre de 2014 / 12:53 / hace 3 años

BUZZ-Prosensa Holding NV: To be bought by BioMarin for about $840 mln

** Dutch drug developer’s shares up about 65 pct at $18.87 premarket; set to open at a more than one-year high

** Company’s shares one of the top percentage gainers among Nasdaq-listed stocks in premarket trading

** BioMarin Pharmaceuticals Inc to buy Prosensa for about $840 million including milestone payments

** Deal will give BioMarin worldwide rights to several orphan-drug candidates including drisapersen, which is being developed to treat Duchenne muscular dystrophy, a rare muscle degeneration disease

** Shares of rival Sarepta Therapeutics Inc, which is also developing a drug to treat DMD, up about 13 pct

** Up to Friday’s close, Prosensa’s shares had more than doubled this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below